Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the Gut Microbiome as Determinant of Depression in Multiple Sclerosis Subjects

NCT05808101 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05808101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05808101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the Gut Microbiome as Determinant of Depression in Multiple Sclerosis Subjects
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Terminated
Start date
January 27, 2022
Completion date
October 29, 2024
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, multiple sclerosis